Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Drug Delivery To Osteoclast Receptor Targets

Rohit Kalvapalle
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1073/pnas.202476899
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling
A. Tee (2002)
10.1074/jbc.272.40.25190
TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*
B. Wong (1997)
10.1016/S0278-2391(03)00720-1
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.
R. Marx (2003)
10.1172/JCI4561
Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.
S. Srivastava (1998)
10.1210/ENDO.136.6.7750484
Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells.
S. Wada (1995)
10.1021/BC970182V
Streptavidin in antibody pretargeting. 2. Evaluation Of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacity.
D. Wilbur (1998)
10.1023/A:1026522619828
Interaction of PTH and PTHrP with Their Receptors
T. Gardella (2004)
10.1172/JCI8905
Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.
K. Mchugh (2000)
10.1038/nm1194
Vav3 regulates osteoclast function and bone mass
R. Faccio (2005)
10.1038/ncb840
Akt regulates growth by directly phosphorylating Tsc2
C. Potter (2002)
10.1359/jbmr.2000.15.4.613
Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib
T. Mashiba (2000)
10.1359/JBMR.041017
Mice Lacking the Integrin β5 Subunit Have Accelerated Osteoclast Maturation and Increased Activity in the Estrogen‐Deficient State
N. Lane (2005)
10.1056/NEJM199610033351403
Esophagitis associated with the use of alendronate.
P. D. de Groen (1996)
10.1016/0149-2918(95)80044-1
Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study.
K. Overgaard (1995)
10.1074/JBC.M302781200
Catalytic Properties of ADAM19*
V. Chesneau (2003)
10.1096/fasebj.12.10.845
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption
Byoung S. Kwon (1998)
10.1016/J.JOCA.2003.08.006
The role of cell seeding density and nutrient supply for articular cartilage tissue engineering with deformational loading.
R. Mauck (2003)
10.1002/JCB.240550303
Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone
A. Parfitt (1994)
Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts.
K. Fuller (1995)
10.1677/JOE.0.1560401
Alternative RNA processing--its role in regulating expression of calcitonin/calcitonin gene-related peptide.
H. Lou (1998)
10.1152/AJPRENAL.1992.262.6.F1110
A cloned porcine renal calcitonin receptor couples to adenylyl cyclase and phospholipase C.
T. Force (1992)
10.1196/annals.1443.016
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
A. Leibbrandt (2008)
10.1016/J.BONE.2004.07.016
Effect of aging on the toughness of human cortical bone: evaluation by R-curves.
R. K. Nalla (2004)
10.1124/MOL.59.2.193
Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation.
A. Reszka (2001)
10.1385/JCD:7:1:17
Diagnosis of osteoporosis in men, premenopausal women, and children.
Thewritinggroupfortheiscdpo (2004)
10.1182/BLOOD.V72.2.830.BLOODJOURNAL722830
Vinculin, talin, and integrins are localized at specific adhesion sites of malignant B lymphocytes
P. Marchisio (1988)
10.1210/MEND.6.4.1316547
A recombinant calcitonin receptor independently stimulates 3',5'-cyclic adenosine monophosphate and Ca2+/inositol phosphate signaling pathways.
O. Chabre (1992)
10.1002/JBMR.5650050415
Bone resorption by isolated osteoclasts in living versus devitalized bone: Differences in mode and extent and the effects of human recombinant tissue inhibitor of metalloproteinases
H. Shimizu (1990)
10.4065/81.5.662
Diagnosis, screening, prevention, and treatment of osteoporosis.
K. Mauck (2006)
10.1016/S0969-8051(96)00162-X
Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody.
M. Zhang (1997)
10.1126/SCIENCE.288.5475.2354
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
R. Siegel (2000)
10.1136/jmg.2004.023895
Association of oestrogen receptor α gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone
O. Albagha (2005)
10.1016/J.BONE.2005.01.023
The morphological association between microcracks and osteocyte lacunae in human cortical bone.
S. Qiu (2005)
10.1210/ENDO.138.2.4905
Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts.
S. Wada (1997)
10.1210/endo.142.1.7919
Minireview: Insights into G protein-coupled receptor function using molecular models.
M. Gershengorn (2001)
10.1016/b978-0-12-528640-4.x5000-x
Osteoporosis in men.
J. M. Campion (2003)
10.1074/jbc.M606656200
Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-κB Ligand*
Atsuhiko Hikita (2006)
10.1128/MCB.01298-06
RANK Overexpression in Transgenic Mice with Mouse Mammary Tumor Virus Promoter-Controlled RANK Increases Proliferation and Impairs Alveolar Differentiation in the Mammary Epithelia and Disrupts Lumen Formation in Cultured Epithelial Acini
Eva González-Suárez (2006)
TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.
R. Josien (1999)
10.1210/MEND.7.8.8232319
Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
D. Ignar-Trowbridge (1993)
10.1016/J.BONE.2006.03.020
Increasing sex difference in bone strength in old age: The Age, Gene/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK).
G. Sigurdsson (2006)
10.1038/nature01658
Osteoclast differentiation and activation
W. Boyle (2003)
10.1073/PNAS.95.7.3597
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
H. Yasuda (1998)
10.1359/jbmr.2000.15.1.20
The Contribution of Trabecular Architecture to Cancellous Bone Quality
D. Dempster (2000)
10.1128/MCB.18.11.6213
MFR, a Putative Receptor Mediating the Fusion of Macrophages
C. Saginario (1998)
10.1091/MBC.E02-07-0389
Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein.
O. Destaing (2003)
10.1091/MBC.E03-10-0745
Vascular endothelial-cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA.
C. Nelson (2004)
10.1210/JC.2003-032081
Perturbed sex steroid status in men with idiopathic osteoporosis and their sons.
I. van Pottelbergh (2004)
10.1210/MEND.7.6.7689695
Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
S. Aronica (1993)
10.1677/JOE.0.1260473
Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways.
M. Zaidi (1990)
10.1016/S0022-5320(72)90017-2
Ultrastructural effects of calcitonin on osteoclasts in tissue culture.
D. M. Kallio (1972)
10.1126/SCIENCE.2528207
Osteoclastic bone resorption by a polarized vacuolar proton pump.
H. Blair (1989)
10.1210/ENDO-70-5-638
Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium.
D. Copp (1962)
Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.
P. Ralph (1977)
10.1007/s002470050708
Calcitonin treatment in osteoectasia with hyperphosphatasia (juvenile Paget's disease): radiographic changes after treatment
B. Tüysüz (1999)
10.1084/JEM.186.12.2075
TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor
B. Wong (1997)
Preparation of a monoclonal antibody directed against the receptor for murine colony-stimulating factor-1.
R. Shadduck (1993)
10.1038/35046102
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
H. Takayanagi (2000)
10.1210/MEND.8.12.7535892
The calcitonin exon and its flanking intronic sequences are sufficient for the regulation of human calcitonin/calcitonin gene-related peptide alternative RNA splicing.
H. Lou (1994)
10.1038/16852
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
Y. Kong (1999)
10.1177/002215540004800207
Osteoclastic Tartrate-resistant Acid Phosphatase (Acp 5): Its Localization to Dendritic Cells and Diverse Murine Tissues
A. R. Hayman (2000)
10.1016/S0092-8674(00)81569-X
Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
D. Lacey (1998)
Cooperation of 5' and 3' processing sites as well as intron and exon sequences in calcitonin exon recognition.
H. Zandberg (1995)
10.1002/PATH.1711360104
Calcitonin alters behaviour of isolated osteoclasts
T. Chambers (1982)
10.1038/ncb839
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K. Inoki (2002)
10.1172/JCI117606
Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
R. Kitazawa (1994)
10.1038/46303
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
Y. Kong (1999)
10.1073/PNAS.96.14.8253
Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats.
T. Shinki (1999)
10.1074/JBC.M106525200
Crystal Structure of the Extracellular Domain of Mouse RANK Ligand at 2.2-Å Resolution*
S. Ito (2002)
10.1016/S1074-7613(00)00041-8
Signaling by the TNF receptor superfamily and T cell homeostasis.
K. F. Chan (2000)
10.4049/jimmunol.169.7.3606
Regulation of Mucosal Dendritic Cell Function by Receptor Activator of NF-κB (RANK)/RANK Ligand Interactions: Impact on Tolerance Induction
E. Williamson (2002)
10.1002/JBMR.5650060610
Biphasic effect of calcitonin on tartrate‐resistant acid phosphatase activity in isolated rat osteoclasts
S. Yumita (1991)
10.1023/A:1007596821702
Regional Differences in Intestinal Spreading and pH Recovery and the Impact on Salmon Calcitonin Absorption in Dogs
Y. Lee (2004)
10.1073/PNAS.0407429101
Mechanotransduction and strain amplification in osteocyte cell processes.
Y. Han (2004)
10.1016/S0140-6736(02)07949-7
A brief history of calcitonin
E. Colman (2002)
10.1016/j.molcel.2008.06.023
DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk.
W. Zou (2008)
10.1172/JCI6145
A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats.
L. Visentin (2000)
10.1021/JM020819I
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
L. Widler (2002)
10.1002/JBMR.5650090802
The diagnosis of osteoporosis
J. Kanis (1992)
10.1016/S0002-9343(99)80251-4
The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women.
A. Grey (1995)
10.1097/BOR.0b013e328172dc1a
New and emerging treatments for osteoporosis
M. Maricic (2007)
10.1002/14651858.CD005326.PUB3
Strontium ranelate for preventing and treating postmenopausal osteoporosis.
S. O'Donnell (2006)
10.2165/00002512-199915040-00004
New Bisphosphonates in the Treatment of Bone Diseases
D. Gatti (1999)
10.1002/DDR.10071
Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption
J. Green (2002)
10.1016/j.abb.2008.03.027
Osteoclast-osteoblast communication.
K. Matsuo (2008)
10.1136/bmj.39440.525752.BE
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
M. Bolland (2008)
Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts.
H. Palokangas (1997)
10.1172/JCI119404
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.
V. W. Engleman (1997)
10.1172/JCI119790
Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts.
K. Insogna (1997)
10.1074/JBC.M002334200
CD47, a Ligand for the Macrophage Fusion Receptor, Participates in Macrophage Multinucleation*
X. Han (2000)
10.1210/MEND.14.1.0401
Multiple domains interacting with Gs in the porcine calcitonin receptor.
P. Orcel (2000)
10.1038/36593
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
D. Anderson (1997)
10.1038/424389a
Endocrinology: Bone adaptation requires oestrogen receptor-α
K. Lee (2003)
10.1113/jphysiol.1990.sp018242
Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.
B. Moonga (1990)
10.1038/345442A0
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
H. Yoshida (1990)
10.1002/JEMT.10374
Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities
J. Delaissé (2003)
10.1126/science.165.3899.1262
Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo
H. Fleisch (1969)
10.1084/JEM.190.12.1741
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
F. Arai (1999)
10.1101/GAD.13.22.2905
Cellular survival: a play in three Akts.
S. Datta (1999)
10.1001/archinte.168.20.2276
Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men.
I. Reid (2008)
10.1016/S1056-8719(00)00075-7
Constitutive receptor systems for drug discovery.
G. Chen (1999)
10.1093/emboj/20.6.1271
Segregation of TRAF6‐mediated signaling pathways clarifies its role in osteoclastogenesis
N. Kobayashi (2001)
10.1074/jbc.M010999200
Downregulation of Small GTPase Rab7 Impairs Osteoclast Polarization and Bone Resorption* 210
H. Zhao (2001)
10.1038/NM1197-1285
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
V. Iotsova (1997)
10.1074/jbc.274.8.4900
Stable Association of PYK2 and p130Cas in Osteoclasts and Their Co-localization in the Sealing Zone*
P. Lakkakorpi (1999)
10.1016/J.ADDR.2004.12.018
Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
K. Väänänen (2005)
10.1016/J.TCB.2005.02.008
Macrophage fusion: are somatic and cancer cells possible partners?
A. Vignery (2005)
10.1152/AJPGI.1984.246.5.G528
Effect of vitamin D3 on duodenal calcium absorption in vivo during early development.
L. A. Dostal (1984)
10.1016/S1471-4892(02)00214-X
Receptor classification: post genome.
S. Foord (2002)
10.1182/BLOOD.V99.1.111
Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.
Xu-Ming Dai (2002)
10.1016/S0092-8674(01)00237-9
The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology
R. Locksley (2001)
10.1111/J.1432-1033.1994.00943.X
Structural characteristics of cross-linking sites in type V collagen of bone. Chain specificities and heterotypic links to type I collagen.
C. Niyibizi (1994)
10.1146/ANNUREV.BI.63.070194.002315
Molecular mechanisms of action of steroid/thyroid receptor superfamily members.
M. Tsai (1994)
Osteoporosis: trends and intervention.
A. Inzerillo (2002)
10.1016/0014-5793(95)00153-Z
Wortmannin, a specific inhibitor of phosphatidylinositol‐3 kinase, blocks osteoclastic bone resorption
I. Nakamura (1995)
10.1002/JBMR.5650100319
Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis
A. Parfitt (1995)
10.1002/(SICI)1098-2795(199701)46:1<104::AID-MRD16>3.0.CO;2-2
Role of c‐Src in cellular events associated with colony‐stimulating factor‐1‐induced spreading in osteoclasts
K. Insogna (1997)
10.1016/0169-6009(92)90883-F
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome.
H. Rico (1992)
10.1084/jem.20050645
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
M. Yagi (2005)
10.1083/JCB.151.4.879
Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones
M. Engsig (2000)
10.1248/CPB.48.1921
Pharmacokinetic disposition of polyethylene glycol-modified salmon calcitonins in rats.
S. Yoo (2000)
10.1083/JCB.146.4.893
Role of Transmembrane 4 Superfamily (Tm4sf) Proteins Cd9 and Cd81 in Muscle Cell Fusion and Myotube Maintenance
I. Tachibana (1999)
10.1073/PNAS.87.12.4828
Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.
W. Wiktor-Jedrzejczak (1990)
10.1084/JEM.178.5.1733
Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts
K. Fuller (1993)
10.1359/jbmr.2001.16.9.1575
Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers
E. Hauge (2001)
10.1359/jbmr.2000.15.12.2330
Expansile Skeletal Hyperphosphatasia: A New Familial Metabolic Bone Disease
M. Whyte (2000)
10.1084/JEM.185.12.2133
In Vivo Detection of Dendritic Cell Antigen Presentation to CD4+ T Cells
E. Ingulli (1997)
10.1038/nrg1122
Genetic regulation of osteoclast development and function
S. Teitelbaum (2003)
10.1016/j.abb.2008.03.037
Osteoclast lineage and function.
H. Väänänen (2008)
10.1016/J.JBIOMECH.2005.06.006
Microdamage: a cell transducing mechanism based on ruptured osteocyte processes.
J. Hazenberg (2006)
10.1016/j.jocd.2007.12.002
Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference.
S. Baim (2008)
10.1172/JCI114975
Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.
R. Pacifici (1991)
10.1210/JC.2003-031448
Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men.
S. Khosla (2004)
10.1210/ENDO.139.7.6112
Phospholipase D- and protein kinase C isoenzyme-dependent signal transduction pathways activated by the calcitonin receptor.
F. Naro (1998)
10.18773/AUSTPRESCR.2000.144
Bisphosphonates - mechanisms of action
T. Martin (2000)
10.1001/JAMA.282.7.637
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
B. Ettinger (1999)
10.1016/S0960-9822(98)70037-5
3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
D. Alessi (1998)
10.1210/JCEM.81.9.8784098
Bone turnover markers and bone density across the menopausal transition.
P. Ebeling (1996)
10.1210/MEND.9.7.7476962
Cell type-specific regulation of transcription by cyclic adenosine 3,'5'-monophosphate-responsive elements within the calcitonin promoter.
Y. T. Monla (1995)
10.1016/S8756-3282(01)00643-3
Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males.
N. Sims (2002)
10.1359/jbmr.2003.18.12.2095
Idiopathic Hyperphosphatasia and TNFRSF11B Mutations: Relationships Between Phenotype and Genotype
Belinda Chong (2003)
10.1046/j.1365-2710.2000.00306.x
Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro‐in vivo evaluation
S. T. Dogru (2000)
10.1016/0021-9290(86)90173-9
Mechanical design in organisms
D. Butler (1986)
10.1016/J.BONE.2004.05.016
Body composition changes with age have gender-specific impacts on bone mineral density.
S. Lim (2004)
10.1046/j.1365-2443.1999.00265.x
Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice
A. Naito (1999)
10.1042/CS0830627
Colonic absorption of human calcitonin in man.
K. Antonin (1992)
10.1210/endo.142.4.8070
Determination of Three Isoforms of the Receptor Activator of Nuclear Factor-κΒ Ligand and Their Differential Expression in Bone and Thymus.
T. Ikeda (2001)
10.1172/JCI13890
Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity.
J. Lam (2001)
10.1172/JCI28775
PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.
D. Mao (2006)
10.1210/JCEM-57-4-819
The sensitivity of isolated osteoclasts to morphological transformation by calcitonin.
T. Chambers (1983)
10.1074/jbc.272.30.18636
Characterization of the Osteoclast Ruffled Border Chloride Channel and Its Role in Bone Resorption*
P. Schlesinger (1997)
10.1046/j.1365-2613.2000.00176.x
Calcitonin and calcitonin receptors: bone and beyond
M. Pondel (2000)
10.1074/jbc.274.37.26393
Macrophage Colony-stimulating Factor Promotes Cell Survival through Akt/Protein Kinase B*
T. Kelley (1999)
10.1359/JBMR.050724
Critical Role of β3 Integrin in Experimental Postmenopausal Osteoporosis
H. Zhao (2005)
10.1038/nm1518
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
K. Loser (2006)
10.1038/nm752
SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts
S. Takeshita (2002)
10.1080/09553000110102021
Radiation-induced changes in gene expression and distribution of atrial natriuretic peptide (ANP) in different anatomical regions of the rat heart
J. C. Kruse (2002)
10.1056/NEJMRA053077
Bone quality--the material and structural basis of bone strength and fragility.
E. Seeman (2006)
10.1038/349117A0
The GTPase superfamily: conserved structure and molecular mechanism
H. Bourne (1991)
The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure.
H. Väänänen (1995)
10.1084/jem.20051150
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
M. Asagiri (2005)
10.1016/J.YEXCR.2003.10.016
Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
Y. Wittrant (2004)
10.7326/0003-4819-108-2-293
Bone densitometry and clinical decision-making in osteoporosis.
B. Riggs (1988)
Osteoblasts release osteoclasts from calcitonin-induced quiescence.
T. Chambers (1982)
10.1016/S8756-3282(99)00214-8
Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.
V. Kartsogiannis (1999)
10.1016/S0002-9343(00)00539-8
What PROOF proves about calcitonin and clinical trials.
S. Cummings (2000)
10.1016/S0002-9343(00)00490-3
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
C. Chesnut (2000)
10.1021/JM049874C
Nonpeptide αvβ3 Antagonists. Part 11: Discovery and Preclinical Evaluation of Potent αvβ3 Antagonists for the Prevention and Treatment of Osteoporosis
P. Coleman (2004)
10.1016/S0092-8674(00)81198-8
Myogenesis: A View from Drosophila
M. Baylies (1998)
10.1074/JBC.273.32.20551
Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.
B. Darnay (1998)
10.3892/IJO.13.1.73
Antitumor vaccine effect of irradiated murine neuroblastoma cells producing interleukin-2 or granulocyte macrophage-colony stimulating factor.
H. Yoshida (1998)
10.1152/AJPENDO.1979.236.1.E15
Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man.
R. Huwyler (1979)
10.1034/j.1600-0854.2003.40206.x
Osteoclast Ruffled Border Has Distinct Subdomains for Secretion and Degraded Matrix Uptake
M. Mulari (2003)
10.1186/AR797
A review of anabolic therapies for osteoporosis
N. Lane (2003)
10.1016/S0092-8674(01)00206-9
Loss of the ClC-7 Chloride Channel Leads to Osteopetrosis in Mice and Man
U. Kornak (2001)
10.1074/JBC.M208284200
U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells*
H. Hotokezaka (2002)
10.1016/0014-5793(86)81338-2
The calcitonin‐like sequence of the β CGRP gene
M. Alevizaki (1986)
10.1084/jem.20040518
RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis
T. Kukita (2004)
10.1172/JCI112584
Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.
G. C. Nicholson (1986)
10.1038/sj.cdd.4401285
M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase
H. Glantschnig (2003)
10.1210/JC.2002-022041
Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study.
Hermien W Goderie-Plomp (2004)
10.1101/GAD.11.21.2835
Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice.
P. Schwartzberg (1997)
10.1101/GAD.11.24.3482
Requirement for NF-κB in osteoclast and B-cell development
G. Franzoso (1997)
10.1074/jbc.273.2.669
The Many Faces of G Protein Signaling*
H. Hamm (1998)
10.1016/j.cell.2008.01.020
Shared Principles in NF-κB Signaling
M. Hayden (2008)
10.1007/s001980170054
Bone-Resorbing Cytokines from Peripheral Blood Mononuclear Cells after Hormone Replacement Therapy: A Longitudinal Study
O. Bernard-Poenaru (2001)
10.1146/ANNUREV.PH.43.030181.003055
PTH, calcitonin, cyclic nucleotides and the kidney.
Z. Agus (1981)
10.1097/01.bor.0000229521.95384.7d
Bone biology and the pathogenesis of osteoporosis
R. Russell (2006)
10.1177/7.1.39
HISTOCHEMICAL DEMONSTRATION OF ACID PHOSPHATASE ACTIVITY IN OSTEOCLASTS
M. S. Burstone (1959)
10.1055/S-2007-1002153
Characterization of the structural and functional properties of cloned calcitonin receptor cDNAs.
S. Goldring (1993)
10.1042/CS0820589
Absorption of human calcitonin across the rat colon in vivo.
J. Hastewell (1992)
10.1210/ENDO-129-6-3313
Modulation of Transforming Growth Factor-β Production in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone
M. J. Oursler (1991)
10.1210/ENDO-127-5-2592
Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse.
R. Felix (1990)
10.1073/PNAS.88.8.3412
Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells.
R. Rotello (1991)
10.1073/PNAS.93.9.3942
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice.
J. M. Shipley (1996)
10.1038/NM1096-1132
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
D. E. Hughes (1996)
10.1523/JNEUROSCI.1484-03.2004
Tetraspanin Protein CD9 Is a Novel Paranodal Component Regulating Paranodal Junctional Formation
T. Ishibashi (2004)
10.1016/J.JCONREL.2007.11.005
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
W. Cheng (2008)
Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts.
T. Sato (1997)
10.1359/jbmr.061113
Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025
R. Burge (2007)
10.1002/JBMR.5650090710
Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold dictyostelium discoideum
M. Rogers (1994)
10.1056/NEJME068003
The long and the short of bone therapy.
M. Whyte (2006)
10.1152/AJPENDO.1984.246.6.E499
Bone histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus.
R. Weinstein (1984)
10.1083/JCB.60.2.346
THE EFFECTS OF PARATHYROID HORMONE, COLCHICINE, AND CALCITONIN ON THE ULTRASTRUCTURE AND THE ACTIVITY OF OSTEOCLASTS IN ORGAN CULTURE
M. E. Holtrop (1974)
10.1081/PDT-65686
Oral Delivery of Mono-PEGylated sCT (Lys18) in Rats: Regional Difference in Stability and Hypocalcemic Effect
S. Mansoor (2005)
Bones: Structure and Mechanics
J. Currey (2002)
10.1210/EDRV-13-1-66
Modulation of osteoclast differentiation.
T. Suda (1992)
Identification of matrix metalloproteinase 9 in rabbit osteoclasts.
K. Tezuka (1994)
10.1042/CS20060046
New mechanisms and targets in the treatment of bone fragility.
T. Martin (2007)
10.1007/978-3-642-77991-6_3
Biology of the Osteoclast
R. Baron (1993)
10.1101/GAD.13.18.2412
RANK is essential for osteoclast and lymph node development.
W. Dougall (1999)
10.1007/s002230020046
Human Osteopetrosis and Other Sclerosing Disorders: Recent Genetic Developments
M. C. Vernejoul (2001)
10.1016/S0002-9440(10)63777-7
Pivotal role of cathepsin K in lung fibrosis.
F. Bühling (2004)
10.1002/JBMR.5650100619
Short‐term local injections of transforming growth factor‐β1 decrease ovariectomy‐stimulated osteoclastic resorption in vivo in rats
J. Beaudreuil (1995)
10.1359/jbmr.2001.16.8.1388
Female Estrogen Receptor β−/− Mice Are Partially Protected Against Age‐Related Trabecular Bone Loss
S. Windahl (2001)
10.1359/jbmr.2002.17.1.77
The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation
V. Everts (2002)
10.1359/jbmr.2002.17.1.26
Expansile Skeletal Hyperphosphatasia Is Caused by a 15‐Base Pair Tandem Duplication in TNFRSF11A Encoding RANK and Is Allelic to Familial Expansile Osteolysis
M. Whyte (2002)
10.1055/S-2007-979008
Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
H. Fleisch (1997)
10.1016/S1074-7613(03)00230-9
TRAF6 is a critical factor for dendritic cell maturation and development.
T. Kobayashi (2003)
10.1210/EDRV.20.3.0370
Estrogen receptor null mice: what have we learned and where will they lead us?
J. F. Couse (1999)
10.1093/emboj/17.15.4391
A β1 integrin signaling pathway involving Src‐family kinases, Cbl and PI‐3 kinase is required for macrophage spreading and migration
F. Meng (1998)
10.1007/s00198-005-2035-9
The role of collagen in bone strength
S. Viguet-Carrin (2005)
10.1359/JBMR.040302
The Chloride Channel Inhibitor NS3736 Prevents Bone Resorption in Ovariectomized Rats Without Changing Bone Formation
S. Schaller (2004)
10.1172/JCI15687
Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.
M. Weitzmann (2002)
10.1038/ni0302-221
NF-κB at the crossroads of life and death
M. Karin (2002)
10.1385/1-59259-813-7:003
Streptavidin-biotin crosslinking of therapeutic enzymes with carrier antibodies: nanoconjugates for protection against endothelial oxidative stress.
V. Shuvaev (2004)
10.1001/JAMA.288.3.321
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
J. Rossouw (2002)
10.1002/JCP.1041320112
Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat bone
T. Chambers (1987)
10.1006/BBRC.1997.6603
Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.
E. Tsuda (1997)
10.1042/BJ2690775
Structure-activity relationship of human calcitonin-gene-related peptide.
M. Zaidi (1990)
10.1113/jphysiol.1989.sp017616
Further evidence for the origin of circulating calcitonin gene‐related peptide in the rat.
P. Emson (1989)
Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones.
L. Blavier (1995)
10.1073/PNAS.89.7.2732
Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.
A. Abou-Samra (1992)
10.1016/8756-3282(95)00180-L
Role of cytokines in bone resorption.
S. Manolagas (1995)
10.1002/JBMR.5650060309
Normocalcemia without hyperparathyroidism in vitamin D‐deficient rats
U. Kollenkirchen (1991)
10.1002/JBMR.5650140212
The pharmacology of bisphosphonates and new insights into their mechanisms of action
R. Russell (1999)
10.1074/jbc.273.43.28355
The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor*
B. Wong (1998)
10.1016/j.beem.2008.07.006
Bone remodelling: its local regulation and the emergence of bone fragility.
T. Martin (2008)
Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
M. Rogers (1995)
10.1016/J.CCR.2005.04.013
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.
C. Lynch (2005)
10.1038/nature02444
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
T. Koga (2004)
10.1073/PNAS.97.4.1566
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.
J. Li (2000)
10.1084/jem.20042081
IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss
M. G. Ruocco (2005)
10.1113/EXPPHYSIOL.1988.SP003168
Effects of peptides from the calcitonin genes on bone and bone cells.
M. Zaidi (1988)
10.1111/J.1445-5994.1986.TB01147.X
The acute biochemical effects of four proprietary calcium preparations.
I. Reid (1986)
10.1038/nm1203
The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis
T. Wada (2005)
10.1007/BF02508638
The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: Evidence of maximal effect after 8 weeks of continuous treatment
M. E. Kraenzlin (2006)
10.1007/BF02285096
Intracolonic bioavailability of human calcitonin in man
C. Beglinger (2005)
10.1101/GAD.10.2.208
An intron enhancer recognized by splicing factors activates polyadenylation.
H. Lou (1996)
10.1385/0-89603-204-3:137
Avidin-biotin technology : preparation of biotinylated probes.
E. Bayer (1992)
10.1016/S0169-409X(00)00064-8
Pulmonary delivery of drugs for bone disorders.
J. S. Patton (2000)
10.1172/JCI7094
Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.
S. Srivastava (1999)
10.1172/JCI27071
Pathogenesis of osteoporosis: concepts, conflicts, and prospects.
L. Raisz (2005)
10.1126/science.150.3702.1465
Thyrocalcitonin: Inhibitor of Bone Resorption in Tissue Culture
J. Friedman (1965)
10.1007/BF02556832
Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women
Diana González (2007)
10.1016/j.ejps.2009.02.004
Lipeo-sCT: a novel reversible lipidized salmon calcitonin derivative, its biophysical properties and hypocalcemic activity.
W. Cheng (2009)
10.1210/MEND.12.12.0213
Granulocyte macrophage-colony stimulating factor reciprocally regulates alphav-associated integrins on murine osteoclast precursors.
M. Inoue (1998)
10.1210/ENDO.140.3.6551
Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism.
D. Inoue (1999)
10.1542/peds.2006-2023H
Bisphosphonates: Mode of Action and Pharmacology
R. Russell (2007)
10.1210/RP.57.1.385
Sex steroids and bone.
S. Manolagas (2002)
10.1001/ARCHINTE.164.8.871
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
I. Reid (2004)
10.1093/HMG/11.18.2119
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.
T. Cundy (2002)
10.1016/J.BERH.2005.06.001
Assessment of fracture risk: who should be treated for osteoporosis?
M. van der Klift (2005)
10.1002/JOR.1100150417
Bone maintenance and remodeling: A control system based on fatigue damage
D. Taylor (1997)
10.1002/jlb.65.6.715
TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
B. Wong (1999)
10.1016/0006-291X(78)91009-4
A cell strain cultured from porcine kidney increases cyclic AMP content upon exposure to calcitonin or vasopressin.
S. Goldring (1978)
10.1016/S0016-5085(98)70491-3
Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors.
C. Ulrich (1998)
10.1074/jbc.271.49.31127
The Deletion of 14 Amino Acids in the Seventh Transmembrane Domain of a Naturally Occurring Calcitonin Receptor Isoform Alters Ligand Binding and Selectively Abolishes Coupling to Phospholipase C*
J. Shyu (1996)
10.1172/JCI3212
PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
L. Dương (1998)
10.1038/nri2062
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
H. Takayanagi (2007)
10.1016/S8756-3282(02)00688-9
Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS.
M. Zaidi (2002)
10.1016/S0092-8674(00)80209-3
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
W. Simonet (1997)
10.1056/NEJMOA062462
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
E. Barrett-connor (2006)
10.1016/S0092-8674(00)00103-3
The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development
J. Fata (2000)
10.1038/SJ.KI.5002518
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.
D. Russo (2007)
10.1093/QJMED/92.3.143
Effect of calcitonin on vertebral and other fractures.
J. Kanis (1999)
10.1172/jci16924
c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation
R. Faccio (2003)
10.1210/MEND.7.8.8232320
Down-regulation of calcitonin gene transcription by vitamin D requires two widely separated enhancer sequences.
S. Peleg (1993)
10.1111/J.1432-1033.1990.TB15493.X
Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin.
B. Schechter (1990)
10.1126/SCIENCE.3283939
The steroid and thyroid hormone receptor superfamily.
R. Evans (1988)
10.2353/AJPATH.2006.060180
B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.
T. Kawai (2006)
10.1101/GAD.13.8.1015
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.
M. A. Lomaga (1999)
10.1016/J.ATHEROSCLEROSIS.2006.08.027
Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study.
M. Rubin (2007)
10.1074/jbc.M602191200
Expression of and Role for Ovarian Cancer G-protein-coupled Receptor 1 (OGR1) during Osteoclastogenesis*
Meiheng Yang (2006)
10.1126/SCIENCE.288.5475.2351
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.
F. K. Chan (2000)
10.1016/S0378-1119(97)00509-X
Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells.
K. B. Tan (1997)
10.1074/JBC.273.51.34120
The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily*
L. Galibert (1998)
10.1038/ng2076
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
C. Sobacchi (2007)
10.1016/S1534-5807(02)00369-6
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.
H. Takayanagi (2002)
10.1007/s007740070007
Osteoclasts, integrins, and osteoporosis
S. Teitelbaum (2000)
10.1126/SCIENCE.276.5310.270
Removal of osteoclast bone resorption products by transcytosis.
J. Salo (1997)
10.1021/mp8000167
Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
W. Cheng (2008)
10.1073/PNAS.92.26.12210
Identification of an inducible surface molecule specific to fusing macrophages.
C. Saginario (1995)
10.1002/(SICI)1097-0215(19971210)73:6<812::AID-IJC7>3.0.CO;2-5
Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers
M. Gillespie (1997)
10.1007/s10165-008-0051-2
Osteoclast cell fusion: mechanisms and molecules
M. Ishii (2008)
10.1359/jbmr.2000.15.1.60
Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo
O. Verborgt (2000)
10.1042/BJ2550377
Peptides from the calcitonin genes: molecular genetics, structure and function.
L. Breimer (1988)
10.1083/JCB.85.3.682
Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat
H. Warshawsky (1980)
10.1016/S0140-6736(80)92592-1
PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN
R. Lindsay (1980)
10.1210/ENDO-128-6-2723
High-affinity androgen binding and androgenic regulation of alpha 1(I)-procollagen and transforming growth factor-beta steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells.
D. Benz (1991)
10.1038/195297A0
Acid Phosphatase Activity in Human Blood Cells
A. Goldberg (1962)
10.1210/endo.141.10.7715
Calcitonin Receptor Regulation and Responsiveness to Calcitonin in Human Osteoclast-Like Cells Prepared in Vitro using Receptor Activator of Nuclear Factor-κB Ligand and Macrophage Colony-Stimulating Factor.
A. Samura (2000)
10.1016/J.AMJMED.2006.02.038
Randomized controlled trial of calcium in healthy older women.
I. Reid (2006)
10.1038/SJ.KI.5002059
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
G. Block (2007)



Semantic Scholar Logo Some data provided by SemanticScholar